Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ashish Mandelia Insider Profile
11 Followers
Ashish Mandelia, VP & CAO at Mersana Therapeutics, holds 47.76K shares in Mersana Therapeutics (Ticker: MRSN).
Ashish Mandelia has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ashish Mandelia's holdings
Insider Roles
VP & CAO
Roles that Ashish Mandelia holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 06, 2020 - Jul 06, 2021
Return:-41.60%
The most profitable trade made by Ashish Mandelia
Ashish Mandelia's Trading History
List of latest transactions for each holding click on a transaction to see Ashish Mandelia's performance on stock
You May Also Like
Ashish Mandelia insider profile FAQ
What is the percentage of profitable transactions made by Ashish Mandelia?
The percentage of profitable transactions made by Ashish Mandelia is ―.
What is the average return per transaction made by Ashish Mandelia?
The average return per transaction made by Ashish Mandelia is ―.
What stocks does Ashish Mandelia hold?
Ashish Mandelia holds: MRSN stocks.
What was Ashish Mandelia’s latest transaction?
Ashish Mandelia latest transaction was an Uninformative Buy of $39.86K.
What was Ashish Mandelia's most profitable transaction?
Ashish Mandelia’s most profitable transaction was an Informative Buy of MRSN stock on July 6, 2020. The return on the trade was -41.60%.
What is Ashish Mandelia's role in Mersana Therapeutics?
Ashish Mandelia's role in Mersana Therapeutics is VP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.